Hu Peng, Yang Qinxin, Wang Qi, Shi Chenshuo, Wang Dali, Armato Ubaldo, Prà Ilaria Dal, Chiarini Anna
1Department of Burns & Plastic Surgery, The Affiliated Hospital of ZunYi Medical University, Dalian Road 149, ZunYi City, 563000 Gui Zhou Province China.
2Human Histology and Embryology Unit, University of Verona Medical School, Strada Le Grazie 8, 37134 Verona, Italy.
Burns Trauma. 2019 Dec 26;7:38. doi: 10.1186/s41038-019-0178-8. eCollection 2019.
Cutaneous regeneration at the wound site involves several intricate and dynamic processes which require a series of coordinated interactions implicating various cell types, growth factors, extracellular matrix (ECM), nerves, and blood vessels. Mesenchymal stromal cells (MSCs) take part in all the skin wound healing stages playing active and beneficial roles in animal models and humans. Exosomes, which are among the key products MSCs release, mimic the effects of parental MSCs. They can shuttle various effector proteins, messenger RNA (mRNA) and microRNAs (miRNAs) to modulate the activity of recipient cells, playing important roles in wound healing. Moreover, using exosomes avoids many risks associated with cell transplantation. Therefore, as a novel type of cell-free therapy, MSC-exosome -mediated administration may be safer and more efficient than whole cell. In this review, we provide a comprehensive understanding of the latest studies and observations on the role of MSC-exosome therapy in wound healing and cutaneous regeneration. In addition, we address the hypothesis of MSCs microenvironment extracellular vesicles (MSCs-MEVs) or MSCs microenvironment exosomes (MSCs-MExos) that need to take stock of and solved urgently in the related research about MSC-exosomes therapeutic applications. This review can inspire investigators to explore new research directions of MSC-exosome therapy in cutaneous repair and regeneration.
伤口部位的皮肤再生涉及几个复杂且动态的过程,这些过程需要一系列协调的相互作用,涉及多种细胞类型、生长因子、细胞外基质(ECM)、神经和血管。间充质基质细胞(MSCs)参与皮肤伤口愈合的所有阶段,在动物模型和人类中发挥着积极有益的作用。外泌体是MSCs释放的关键产物之一,可模拟亲代MSCs的作用。它们可以转运各种效应蛋白、信使核糖核酸(mRNA)和微小核糖核酸(miRNAs)来调节受体细胞的活性,在伤口愈合中发挥重要作用。此外,使用外泌体可避免许多与细胞移植相关的风险。因此,作为一种新型的无细胞疗法,MSC-外泌体介导的给药可能比全细胞更安全、更有效。在这篇综述中,我们全面了解了关于MSC-外泌体疗法在伤口愈合和皮肤再生中作用的最新研究和观察结果。此外,我们探讨了间充质基质细胞微环境细胞外囊泡(MSCs-MEVs)或间充质基质细胞微环境外泌体(MSCs-MExos)的假说,这在MSC-外泌体治疗应用的相关研究中需要迫切评估和解决。这篇综述可以启发研究人员探索MSC-外泌体疗法在皮肤修复和再生中的新研究方向。